Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M513772200 on February 20, 2006

J. Biol. Chem., Vol. 281, Issue 16, 11186-11192, April 21, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/16/11186    most recent
M513772200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, A. L.
Right arrow Articles by Nizet, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, A. L.
Right arrow Articles by Nizet, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Group B Streptococcal Sialic Acid O-Acetyltransferase Is Encoded by neuD, a Conserved Component of Bacterial Sialic Acid Biosynthetic Gene Clusters*

Amanda L. Lewis{ddagger}§1, Mary E. Hensler, Ajit Varki§||**, and Victor Nizet§2

From the {ddagger}Division of Biological Sciences and the Departments of Pediatrics, ||Medicine, and **Cellular and Molecular Medicine, and the §Glycobiology Research and Training Center, School of Medicine, University of California San Diego, California 92093-0687

Received for publication, December 27, 2005 , and in revised form, February 6, 2006.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nearly two dozen microbial pathogens have surface polysaccharides or lipo-oligosaccharides that contain sialic acid (Sia), and several Sia-dependent virulence mechanisms are known to enhance bacterial survival or result in host tissue injury. Some pathogens are also known to O-acetylate their Sias, although the role of this modification in pathogenesis remains unclear. We report that neuD, a gene located within the Group B Streptococcus (GBS) Sia biosynthetic gene cluster, encodes a Sia O-acetyltransferase that is itself required for capsular polysaccharide (CPS) sialylation. Homology modeling and site-directed mutagenesis identified Lys-123 as a critical residue for Sia O-acetyltransferase activity. Moreover, a single nucleotide polymorphism in neuD can determine whether GBS displays a "high" or "low" Sia O-acetylation phenotype. Complementation analysis revealed that Escherichia coli K1 NeuD also functions as a Sia O-acetyltransferase in GBS. In fact, NeuD homologs are commonly found within Sia biosynthetic gene clusters. A bioinformatic approach identified 18 bacterial species with a Sia biosynthetic gene cluster that included neuD. Included in this list are the sialylated human pathogens Legionella pneumophila, Vibrio parahemeolyticus, Pseudomonas aeruginosa, and Campylobacter jejuni, as well as an additional 12 bacterial species never before analyzed for Sia expression. Phylogenetic analysis shows that NeuD homologs of sialylated pathogens share a common evolutionary lineage distinct from the poly-Sia O-acetyltransferase of E. coli K1. These studies define a molecular genetic approach for the selective elimination of GBS Sia O-acetylation without concurrent loss of sialylation, a key to further studies addressing the role(s) of this modification in bacterial virulence.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Sialic acids (Sias)3 are a family of related nine-carbon acidic sugars (nonulosonic acids) that are found at the outer ends of glycan chains on all vertebrate cells. Over 20 microbial pathogens are known to use surface Sia decoration as a form of molecular mimicry that is often crucial to virulence (1). Several convergent strategies for microbial Sia decoration have been identified, including endogenous biosynthesis, scavenging, or direct transfer of host Sias to their own surface glycans (1). Heavily sialylated bacteria often cause sepsis and meningitis by exhibiting Sia-dependent serum resistance due to deactivation of the alternative complement pathway (2-4). In addition, bacterial Sias can enhance intracellular survival (5), participate in biofilm formation (6), or mask underlying antibody epitopes (7). Antibodies elicited against sialylated bacterial glycolipids can also cross-react with host peripheral nerve axons, leading to the debilitating autoimmune disorder called Guillain-Barré syndrome (8, 9). In short, there are multiple Sia-dependent virulence mechanisms that enhance bacterial survival and/or result in host tissue injury.

Several pathogenic bacteria are known to modify Sia residues by O-acetylation (10-18). In other contexts, O-acetylation alters immunogenicity of polysaccharide epitopes (19-21), affects Sia-dependent interactions with host leukocyte receptors and complement (22), and can have intracellular consequences for apoptotic regulation (36). Despite the potential of Sia O-acetylation to affect pathologic processes, little is known of its role at the host-pathogen interface. Elucidation of the molecular genetic basis of this modification is critical for mechanistic understanding of Sia as a microbial virulence determinant.

Group B Streptococcus (GBS) is the leading cause of sepsis and meningitis in human newborn infants and is increasingly associated with invasive infections in adult patient populations (23). The surface capsular polysaccharides (CPS) of all nine identified GBS serotypes invariably display a terminal {alpha}2-3-linked N-acetylneuraminic acid (Neu5Ac), the predominant Sia on the surface of human cells. Recently, we discovered that these Neu5Ac residues are modified with various levels of O-acetylation (17). Due to the chemical lability of O-acetyl esters, nearly three decades of previously published investigations on the biochemistry of the GBS CPS addressed neither the presence of Sia O-acetylation nor its potential implications for pathogenesis and immunogenicity. We demonstrate the genetic basis for Sia O-acetylation in GBS, including a polymorphism associated with variation in O-acetylation levels among clinical GBS strains. We show that the GBS Sia O-acetyltransferase, NeuD, is itself required for CPS sialylation, a role that can be separated from its O-acetyltransferase activity. A bioinformatic approach further revealed that neuD homologs are present within many bacterial Sia biosynthetic gene clusters.


   EXPERIMENTAL PROCEDURES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
RESULTS
 DISCUSSION
 REFERENCES
 
Strains and Culture Conditions, DNA Isolation, and PCR—Wild-type (WT) serotype III GBS strain COH1 was the background for all isogenic modifications. GBS were propagated on Todd-Hewitt agar plates or liquid broth at 37 °C without shaking unless specified, with 10 µg/ml erythromycin or 2 µg/ml chloramphenicol selection when indicated. Escherichia coli K1 strain ATCC 23511 was propagated in Luria broth (or agar) at 37 °C.

Allelic Replacement Mutagenesis—Precise in-frame allelic replacement of the GBS neuD gene with the chloramphenicol acetyltransferase (cat) gene was performed as described previously for allelic replacement of the GBS iagA gene (24). The primers used to amplify neuD upstream and downstream flanking sequences were: NeuDF 5'-gctacatggagaaagtgtag-3' + NeuDIOF 5'-cattttagattattctcctttaaatca-3', and NeuDR 5'-caatgtcgtaaacagaccag-3' + NeuDIOR 5'-taaaggatatgttatgaagccaatttg-3', respectively. The temperature-sensitive targeting plasmid pNeuD-KO derived by this technique was used to transform WT COH1. Differential temperature and antibiotic selection (17) facilitated precise allelic replacement of neuD with cat to yield mutant COH1{Delta}NeuD, as confirmed by direct sequence analysis of chromosomal DNA. Slight modifications of the same protocol were used to generate a derivative of COH1 containing a single base pair mutation in neuD changing residue 88 of the encoded protein from phenylalanine to cysteine (F88C). The targeting vector was generated from a NeuDF + NeuDR PCR amplicon of type II GBS strain DK23 bearing the identified neuD polymorphism. This vector was used to transform COH1{Delta}NeuD with temperature shifts and differential antibiotic selection identifying a chloramphenicol-sensitive mutant in which cat was precisely replaced with the DK23 neuD gene. The resulting mutant (COH1-NeuDF88C) was confirmed by direct sequence analysis to be identical to WT COH1 except bearing the DK23 version of neuD.

Complementation Studies—WT GBS COH1 neuD was subcloned from the pCR2.1 vector above into streptococcal expression vector pDCerm (25), yielding pGBS-NeuD. E. coli K1 strain ATCC23511 neuD was amplified using primers 5'-cgtctagacgatgagtaaaaagttaataatatttggtgcggg-3' and 5'-cgggatcccgttcattccccctaattaatcttgttgg-3' based on published sequence (26) and cloned into pDCerm to produce pEcK1-NeuD. Sequencing of neuD from strain ATCC23511 revealed 99.5% identity with the published neuD sequence of E. coli K1 RS218 (NCBI accession number AAC43301 [GenBank] ), differing only at residue 164, where cysteine replaces valine. Each NeuD expression construct was used to transform electrocompetent COH1{Delta}NeuD, and the resulting erythromycin-resistant transformants were analyzed by 1,2-diamino-4,5-methylene dioxybenzene derivatization and HPLC as below.

Site-directed Mutagenesis—Site-directed mutagenesis of NeuD lysine 123 to alanine in pGBS-NeuD plasmid was accomplished by QuikChange (Stratagene) using the PAGE-purified primer 5'-ggggcttttataggttctaaagtggcgctgtttgataacaacg-3' and its reverse complement followed by DpnI digestion to remove residual template. DNA isolated by ethanol precipitation was transformed into electrocompetent E. coli MC1061, and plasmid pGBS-NeuD-K123A was confirmed by sequencing to harbor only the single residue change in the neuD coding region.

Release, 1,2-Diamino-4,5-methylene Dioxybenzene Derivatization, and HPLC Analysis and Quantitation of Sialic Acids—Sias were released from phosphate-buffered saline-washed GBS using 2 N acetic acid for 3 h at 80°C (27). Acid release is known to induce some migration of O-acetyl esters from the 7-9-carbon positions (27); this behavior has also been documented for GBS (17). Sias released from GBS were fluorescently labeled with 1,2-diamino-4,5-methylene dioxybenzene and resolved by reverse phase HPLC as described (17). Peaks were assigned based on retention times of standard sialic acids, as well as NaOH lability of O-acetyl esters (17).

Homology Modeling—Homology modeling of NeuD was based on the Protein Data Bank coordinates (1KRR [PDB] ) of the E. coli galactoside acetyltransferase (GAT) in complex with acetyl-coenzyme A. Modeling was accomplished using the program Modeler 7v7 (Andrej Sali) and an alignment of the two sequences produced by clustalX. The root mean square difference between GAT coordinates and the modeled NeuD structure was determined using the Unix-based program O using residues 83-99 and 105-144 of GAT and residues 91-107 and 111-160 of NeuD. Energy parameters as determined by Modeler were acceptable with no error messages during execution of the script. PROCHECK was used to generate Ramachandran plots of both the experimentally determined (GAT) and the modeled (NeuD) coordinates, each showing two residues near the C terminus in disallowed regions of the plot. Reconstruction of the modeled NeuD trimer complete with the coordinates of acetyl-coenzyme A from 1KRR was performed using the program O.

Bioinformatic Approach for Locating neuD Homologs in Sia Biosynthetic Clusters—We compiled lists of organisms that encode homologs of each of the GBS gene products (NeuA-D) with characterized roles in Sia biosynthesis. BLAST searches on the public domain NCBI data base were performed using sequences of the four GBS genes. Alternatively, the "Clusters of Orthologous Groups of proteins," or the COG system (28), available through The Institute for Genomic Research (TIGR) microbial genome data base, was used to generate lists of organisms with NeuA-D homologs. The four lists were compared and compiled manually to determine which organisms contained all four biosynthetic genes. Although there are a few cases in which the UDP-GlcNAc epimerase (NeuC) is encoded separately, we only included organisms that had a clearly defined clustering of Sia biosynthetic genes (see accession numbers). Note that the term "Sia biosynthetic clusters" is used to describe gene arrangements and their homologies, without necessarily implying the production of Sias.

Phylogenetic Analysis of Bacterial Hexapeptide Repeat Family O-Acetyltransferases—ClustalX was used to produce a multiple alignment comparing NeuD amino acid sequences with Sia O-acetyltransferases (NeuO and OatWY) from E. coli (AAX11174 [GenBank] ) and Neisseria meningitidis (CAC38867 [GenBank] ), serine acetyltransferases from E. coli (NP_312512 [GenBank] ) and Zea mays (corn; AAN76864 [GenBank] ), and E. coli GAT (NP414876) and MAT (maltose O-acetyltransferase, P77791 [GenBank] ). A Nexus file format of the multiple alignment was used in PAUP 4.0b10 to create an unrooted parsimony tree using the "heuristic search" command with default settings.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
DISCUSSION
 REFERENCES
 
NeuD Is Involved in Sia Biosynthesis—We previously speculated that the GBS neuD gene may encode a Sia O-acetyltransferase (17). This hypothesis was based on its physical location (clustered with other GBS Sia biosynthesis genes) and its homology to hexapeptide repeat acetyltransferases of the CysE/LacA/LpxA/NodL family. Non-polar allelic replacement mutagenesis of neuD in WT GBS COH1 resulted in severe attenuation of overall Sia biosynthesis and O-acetylation (Fig. 1A). The COH1{Delta}NeuD mutant lost buoyancy and precipitated readily from static culture, consistent with the requirement of sialylation for maximal CPS expression in GBS (29). Both Sia biosynthesis and O-acetylation could be restored to the COH1{Delta}NeuD mutant by complementation in trans with pGBS-NeuD (Fig. 1A). Higher levels of O-acetylation upon overexpression of NeuD on the high copy number complementation vector likely reflect stoichiometric constraints for proper functions that are common among biosynthetic complexes. The simple mutagenesis and complementation analysis proved insufficient to define the hypothesized role of NeuD as an O-acetyltransferase. We thus undertook further studies to dissect the potential dual functions of NeuD in Sia biosynthesis and O-acetylation.

NeuD Is the GBS Sia O-Acetyltransferase—A strategy of site-directed mutagenesis was employed to discriminate between hypothetical dual functions of NeuD in GBS Sia biosynthesis and Sia O-acetylation. Homology modeling of NeuD was used to predict a residue in the proposed GBS NeuD active site that would be specifically involved in O-acetyl transfer to Sia residues. The aim was to complement the asialo-COH1{Delta}NeuD mutant with a modified version of GBS neuD that could still perform the presumed Sia biosynthetic function but not the O-acetyltransferase function. The GBS NeuD model in Fig. 1B is based on the crystal structure of the E. coli GAT (Protein Data Bank number 1KRR [PDB] ). Overlay of these molecules reveals a striking similarity in three-dimensional structure, despite only 16% identity between their primary sequences. When compared with the 2.5 Å resolution structure of GAT (30), the GBS NeuD model had a root mean square difference of 1.04 over 55 amino acids involved in the left-handed beta-helix domain of this enzyme family. Examination of the GBS NeuD model predicted lysine residue 123 to be involved in the critical acetyl-coenzyme A binding function (Fig. 1B). GBS NeuD also contains a lysine residue at position 121 that may be involved in the acetylation reaction. We chose Lys-123 for mutagenesis because it aligns with His-115 of the E. coli galactoside acetyltransferase (Fig. 1C), which is predicted to abstract a proton from the acceptor hydroxyl group, allowing attack of the resulting carbonyl by acetyl CoA (31). Site-directed mutagenesis was used to change NeuD lysine 123 to alanine. The resulting plasmid (pGBS-NeuD-K123A) was introduced by electroporation into GBS mutant COH1{Delta}NeuD. As predicted, the NeuD-K123A plasmid restored Sia biosynthesis to the {Delta}NeuD mutant. In contrast, O-acetylation of Neu5Ac was barely detectable (Fig. 1D), indicating that NeuD is indeed the GBS Sia O-acetyltransferase and that Lys-123 is required for efficient acetyl transfer. These data suggest that despite their ancient relationship, GAT and NeuD likely share a similar mechanism of action.


Figure 1
View larger version (59K):
[in this window]
[in a new window]
  		FIGURE 1.
NeuD is the GBS sialic acid O-acetyltransferase. A, HPLC resolution of fluorescently labeled Sias isolated from WT GBS strain COH1, neuD allelic replacement mutant COH1{Delta}NeuD ({Delta}NeuD), and mutant complemented with neuD on an expression plasmid. Loss of neuD markedly reduces GBS sialylation. B, homology model of the NeuD trimer depicting lysine 123 in putative interaction with acetyl-coenzyme A based upon the known structure of E. coli galactoside acetyltransferase. C, Clustalx alignment of GBS NeuD with the E. coli GAT used for homology modeling. Arrows indicate lysine residues 121 and 123; the latter aligns with His-115 of GAT. D, complementation of the COH1{Delta}NeuD mutant with the K123A mutant of NeuD restores sialylation but not O-acetylation. Neu5Ac is N-acetylneuraminic acid, and Neu5,7Ac2, Neu5,8Ac2, and Neu5,9Ac2, refer to the 7-, 8-, and 9-O-acetylated versions of Neu5Ac. R refers to a reagent peak of unknown identity.

 
A neuD Polymorphism Associated with Varied O-Acetylation Levels among GBS Strains—During our initial discovery of Neu5Ac O-acetylation in GBS CPS, we noted that clinical isolates expressed either higher (40-55%) or lower (2-15%) levels of this Sia modification (17). To probe the basis for this GBS strain variation in Sia O-acetylation, we sequenced the complete neuD gene from three strains belonging to each group ("high OAc" versus "low OAc"). We found that a single non-synonymous nucleotide change correlated with O-acetylation status, wherein high OAc strains (including COH1) had a thymine at position 264, and low OAc strains had a guanine at that position. This polymorphism leads to an amino acid coding change at position 88, with phenylalanine in high OAc strains and cysteine in low OAc strains (Fig. 2A). To ascertain whether a functional relationship existed between the identified nucleotide polymorphism and the observed levels of Sia O-acetylation, the neuD gene of low OAc serotype II strain DK23 was used to precisely replace the native neuD gene within the chromosome of high OAc WT strain COH1 (see "Experimental Procedures"). The resulting "knock-in" mutant COH1-NeuDF88C, differing from WT COH1 by just the single nucleotide polymorphism in neuD, was found to exhibit a low OAc phenotype (Fig. 2B). This result identifies the existence of at least one specific genetic polymorphism that contributes functionally to variation in total O-acetylation levels among GBS strains.


Figure 2
View larger version (29K):
[in this window]
[in a new window]
  		FIGURE 2.
A single nucleotide polymorphism in NeuD associated with variant GBS O-acetylation (O-Ac) phenotype. A, sequence polymorphism in NeuD from GBS clinical strains exhibiting high or low O-acetylation phenotypes. B, precise chromosomal replacement of WT COH1 neuD with the F88C polymorphic version converts the strain from a high OAc to low OAc phenotype. See the legend for Fig. 1 for a description of the HPLC peaks.

 
E. coli K1 neuD Encodes an Active Sia O-Acetyltransferase—Homologs of the GBS Sia biosynthetic enzymes (NeuA, B, and C) can be identified in a number of other organisms including sialylated pathogens and their human hosts. Like GBS, E. coli K1 is a leading cause of neonatal sepsis and meningitis, expresses a surface CPS containing Neu5Ac, and further modifies this Sia by O-acetylation (10, 32). E. coli K1 also has a homolog of the GBS neuD gene alongside the Sia biosynthetic cluster. Earlier studies demonstrated that disruption of the E. coli K1 neuD gene leads to total loss of Sia expression and that Sia expression could be restored to the resulting mutant by introduction of plasmids expressing either the E. coli K1 or the GBS versions of NeuD (33). Discovery of the NeuO poly-Sia O-acetyltransferase (34), coupled with an experiment in which the complete E. coli K1 Sia gene cluster (including neuD) failed to confer CPS Sia O-acetylation to a non-K1 E. coli host (35), led the investigators to a logical conclusion that a role for NeuD in Sia O-acetylation was unlikely for either GBS or E. coli K1 (34). Despite these considerations, the current studies allowed us to conclude that NeuD is in fact the GBS Sia O-acetyltransferase. Thus, we next asked whether the homologous E. coli K1 NeuD also has demonstrable Sia O-acetyltransferase activity. Expression vector pNeuD-EcK1, containing the neuD gene of E. coli K1 strain ATCC23511, was introduced into the asialo-GBS mutant COH1{Delta}NeuD and was observed to restore both Sia biosynthesis and high levels of O-acetylation (Fig. 3). This result indicates that despite only 30% sequence identity between the GBS and E. coli K1 NeuD enzymes, they are both able to carry out Sia biosynthetic and O-acetyltransferase functions in GBS.

NeuD Homologs Are Broadly Represented among Bacterial Species— Given the orthologous relationship between GBS and E. coli K1 neuD genes, we explored whether neuD is a common component of Sia biosynthetic clusters. Using a bioinformatic approach, we found neuD homologs that are physically associated with Sia biosynthetic gene clusters in the genomes of 18 bacterial species (Fig. 4, A and B), many of which have not to date been analyzed for Sia expression (Fig. 4B) Phylogenetic analysis indicates that NeuD homologs of sialylated pathogens (in Fig. 4A) have a common evolutionary lineage, distinct from chloramphenicol, maltose, galactoside, and serine acetyltransferases (Fig. 4C). The tree also shows that the Sia O-acetyltransferases from E. coli (NeuO) and N. meningitidis (OatWY), which likely both act on polysialic acid, evolved independently from the NeuD subfamily, appearing more closely related to maltose and galactoside acetyltransferases. A second predicted O-acetyltransferase of this family in the GBS genome (AAM99894 [GenBank] ) clusters phylogenetically with the maltose and galactoside acetyltransferases (Fig. 4C). Single crossover (Campbell-type) plasmid integrational disruption of this gene in WT GBS strain COH1 resulted in no change in overall sialylation or O-acetylation (data not shown), indicating that it is not involved in either of these processes.


Figure 3
View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 3.
E. coli K1 NeuD is a functional O-acetyltransferase. HPLC analysis of fluorescently labeled total sialic acids from the GBS {Delta}NeuD mutant before and after transformation with a plasmid expressing NeuD from E. coli K1. See the legend for Fig. 1 for a description of the HPLC peaks.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
REFERENCES
 
In the present work, we show that NeuD has dual roles in GBS sialylation and Sia O-acetylation that can be distinguished using site-directed mutagenesis. We identified Lys-123 as a critical residue for efficient acetyl transfer and demonstrate that a naturally occurring single residue polymorphism in the neuD coding region allows variation in the GBS O-acetylation phenotype. Complementation analysis shows that E. coli K1 neuD also encodes an active Sia O-acetyltransferase within the context of the GBS biosynthetic machinery. Indeed, neuD homologs are found within Sia biosynthetic gene clusters in at least 18 bacterial species, 12 of which are not currently known to synthesize Sias. On mammalian cells, Sia O-acetylation can affect apoptotic regulation (36), susceptibility to alternative complement, tissue tropism, and binding to leukocyte-expressed Sia-binding proteins (22). Due to past issues of chemical lability and genetic intractability, understanding the role(s) of bacterial Sia O-acetylation has been very difficult. These studies offer a specific approach to experimentally assess the importance of this modification in bacterial pathogenesis.

Pathogenic strains of E. coli and C. jejuni that cause bloody diarrhea in humans often express Neu5Ac as part of their lipo-oligosaccharides (15, 37). Although the E. coli O104 antigen is known to be O-acetylated (15), this modification has not been reported for E. coli O145 or lipo-oligosaccharides of any Campylobacter species. O-acetylation of lipo-oligosaccharide Sia is especially relevant because mimicry of host gangliosides is felt to be a pivotal factor in the autoimmune damage to motor axons that characterizes Campylobacter-associated Guillain-Barré syndrome (8). Serum antibodies recognizing O-acetyl forms of gangliosides GD1b, GD3, or GT3 have been identified in subsets of patients with this nervous system disorder (38, 39). We identify NeuD homologs in the Sia biosynthetic clusters of C. jejuni, E. coli O104, and E. coli O145 (Fig. 4).


Figure 4
View larger version (54K):
[in this window]
[in a new window]
  		FIGURE 4.
NeuD is conserved among bacterial Sia biosynthetic gene clusters. A, schematic representations of Sia biosynthetic gene clusters of bacteria known to synthesize N-acetylneuraminic (Neu) acid, Leg, or Pse. Letter designations refer to homologs of known GBS enzymes: NeuC, which catalyzes the epimerization of UDP-GlcNAc to N-acetyl mannosamine (49); NeuB, which carries out the condensation of N-acetyl mannosamine and phosphoenolpyruvate to form Neu5Ac (50); and NeuA, which activates Neu5Ac with CTP to generate CMP-Neu5Ac (51). Core Sia structures are marked with arrows to indicate reported O-acetylation (OAc) sites. Accession numbers are from NCBI or TIGR. B, additional bacterial species possessing Sia biosynthetic gene clusters (NeuA-D) but as yet not known to synthesize Sia. C, parsimony-based phylogenetic tree indicating the relationship of putative NeuD orthologs to other hexapeptide acetyltransferases including GAT, maltose O-acetyltransferase (MAT), CAT, serine acetyltransferase (SAT), or polysialic acid acetyltransferases of E. coli (NeuO) or N. meningitides (N.meni) (OatWY). AAM99894 [GenBank] is a second O-acetyltransferase of this family in the GBS genome. C.jej, C. jejuni; P.aer, P. aeruginosa; V.par, V. parahemeolyticus; L.pneumo, L. pneumophila.

 
Some bacterial agents of pneumonia synthesize nine-carbon acidic sugars that are structurally similar to Neu5Ac using homologous biosynthetic pathways (40). These sugars, known as legionaminic acids (Leg) and pseudaminic acids (Pse) (Fig. 4A), have been called "Sia-like" molecules (41) and are found in over a dozen bacterial species including L. pneumophila, P. aeruginosa, and pathogenic Vibrio spp (42). Biochemical analysis has shown that Leg and Pse molecules on the surfaces of L. pneumophila, P. aeruginosa, and C. jejuni are modified by O-acetylation (12, 14, 16). We now show that like the Neu5Ac biosynthetic clusters, both Leg and Pse biosynthetic clusters also include a neuD homolog (Fig. 4A), further supporting the evolutionary relationship between these biosynthetic pathways and their inclusion in the larger category of Sias. The presence of NeuD in Leg and Pse biosynthetic clusters predicts a genetic basis for O-acetylation of these related sugars.

Unlike the poly-Sia O-acetyltransferases of E. coli K1 and N. meningitidis, we could not reliably align the legionaminic acid O-acetyltransferase of L. pneumophila to analyze its relationship with other enzymes in this family. Initial studies of a L. pneumophila Lag-1 mutant strongly suggested its role as a Leg O-acetyltransferase (43). It was later recognized, however, that L. pneumophila often expresses Lag-1-independent O-acetylation of Leg residues in the LPS core region (44). Thus, the L. pneumophila neuD homolog represents a candidate gene for the remaining O-acetylation in the lag-1 mutant. It is theoretically possible that, like L. pneumophila, E. coli K1 strains express NeuO-independent O-acetylation of Sia moieties that are not accessible to specific polyclonal antisera used for O-acetyl analysis. Alternatively, NeuD may only be functional as an O-acetyltransferase in E. coli strains that produce sialylated lipo-oligosaccharide antigens (O104 and O145). If the latter were the case, K1 neuD would be conserved in this biosynthetic gene cluster solely for its role in sialylation. Further studies are needed to determine the actual roles of neuD homologs in these bacteria.

Of the 18 bacterial species we identified using our bioinformatic approach, 12 are not currently known to express Sias (Fig. 4B). Among these are the human pathogens Vibrio vulnificans, causing wound infections and septicemia (45), Chromobacterium violaceum, an agent of serious invasive disease in pediatric age groups (46), and Leptospira interrogans, a leading zoonotic pathogen producing systemic illnesses manifest by hepatic and renal dysfunction (47). For investigators working with each of these species, our identification of Sia gene clusters containing neuD may stimulate a search for the presence of Sias with O-acetyl modifications that likely play a role in environmental niche ecology and/or interactions with mammalian hosts.

Although we have not precisely defined the duality of the role of NeuD in bacterial Sia biosynthesis, others have presented evidence that the E. coli K1 NeuD protein interacts with NeuB, the sialic acid synthetase (48). Our data are consistent with previous speculation that NeuD may play a structural role in stabilization of a Sia biosynthetic complex of enzymes (48), distinct from its O-acetyltransferase activity. Further investigations of the genetic basis and functional role of O-acetylation in Legionella, Pseudomonas, Campylobacter, Leptospira, Vibrio, etc. may require a similar approach to the present one, involving site-directed active site mutagenesis to discriminate between these dual biosynthetic roles. Some pathogens including N. meningitidis may have lost the requirement for NeuD in Sia biosynthesis since a corresponding gene is not easily discernable near the Sia biosynthetic cluster. Notably, unlike the other components of the Sia biosynthesis pathway (NeuA-C), which share homology between humans and bacteria (Fig. 4B), there are no mammalian homologs of any hexapeptide repeat acetyltransferase, including NeuD. Thus, NeuD may represent a unique bacterial target for rational drug design aimed at eliminating surface expression of sialic acid, a virulence phenotype of several human pathogens.


   FOOTNOTES
 
* This work was funded by National Institutes of Health Grants R01HD051796 (to V. N.), R01GM32373 (to A. V.), and P01HL57345 (to A. V.) and an American Heart Association Established Investigator Award (to V. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

1 Supported by University of California, San Diego Institutional National Institutes of Health Training Grant 5 T32 DK07202. Back

2 To whom correspondence should be addressed. Tel.: 858-534-7408; Fax: 858-534-5611; E-mail: vnizet{at}ucsd.edu.

3 The abbreviations used are: Sia, sialic acid; GBS, Group B Streptococcus; Neu5Ac, N-acetylneuraminic acid; CPS, capsular polysaccharide; GAT, galactoside acetyltransferase; CAT, chloramphenicol acetyltransferase; WT, wild type; HPLC, high pressure liquid chromatography; Leg, legionaminic acid; Pse, pseudaminic acids. Back


   ACKNOWLEDGMENTS
 
We thank Russell Doolittle for guidance in homology modeling and Warren Lewis for assistance with ChemDraw.



   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Vimr, E., and Lichtensteiger, C. (2002) Trends Microbiol. 10, 254-257[CrossRef][Medline] [Order article via Infotrieve]
  2. Marques, M. B., Kasper, D. L., Pangburn, M. K., and Wessels, M. R. (1992) Infect. Immun. 60, 3986-3993[Abstract/Free Full Text]
  3. Vogel, U., Weinberger, A., Frank, R., Muller, A., Kohl, J., Atkinson, J. P., and Frosch, M. (1997) Infect. Immun. 65, 4022-4029[Abstract]
  4. Ram, S., Sharma, A. K., Simpson, S. D., Gulati, S., McQuillen, D. P., Pangburn, M. K., and Rice, P. A. (1998) J. Exp. Med. 187, 743-752[Abstract/Free Full Text]
  5. Charland, N., Kobisch, M., Martineau-Doize, B., Jacques, M., and Gottschalk, M. (1996) FEMS Immunol. Med. Microbiol. 14, 195-203[CrossRef][Medline] [Order article via Infotrieve]
  6. Jurcisek, J., Greiner, L., Watanabe, H., Zaleski, A., Apicella, M. A., and Bakaletz, L. O. (2005) Infect. Immun. 73, 3210-3218[Abstract/Free Full Text]
  7. Guerry, P., Ewing, C. P., Hickey, T. E., Prendergast, M. M., and Moran, A. P. (2000) Infect. Immun. 68, 6656-6662[Abstract/Free Full Text]
  8. Hughes, R. A., and Cornblath, D. R. (2005) Lancet 366, 1653-1666[CrossRef][Medline] [Order article via Infotrieve]
  9. Koga, M., Takahashi, M., Masuda, M., Hirata, K., and Yuki, N. (2005) Neurology 65, 1376-1381[Abstract/Free Full Text]
  10. Orskov, F., Orskov, I., Sutton, A., Schneerson, R., Lin, W., Egan, W., Hoff, G. E., and Robbins, J. B. (1979) J. Exp. Med. 149, 669-685[Abstract/Free Full Text]
  11. Bhattacharjee, A. K., Jennings, H. J., Kenny, C. P., Martin, A., and Smith, I. C. (1976) Can. J. Biochem. 54, 1-8[CrossRef][Medline] [Order article via Infotrieve]
  12. Knirel, Y. A., Vinogradov, E. V., Shashkov, A. S., Dmitriev, B. A., Kochetkov, N. K., Stanislavsky, E. S., and Mashilova, G. M. (1986) Eur. J. Biochem. 157, 129-138[Medline] [Order article via Infotrieve]
  13. Knirel, Y. A., Kocharova, N. A., Shashkov, A. S., Dmitriev, B. A., Kochetkov, N. K., Stanislavsky, E. S., and Mashilova, G. M. (1987) Eur. J. Biochem. 163, 639-652[Medline] [Order article via Infotrieve]
  14. Thibault, P., Logan, S. M., Kelly, J. F., Brisson, J. R., Ewing, C. P., Trust, T. J., and Guerry, P. (2001) J. Biol. Chem. 276, 34862-34870[Abstract/Free Full Text]
  15. Gamian, A., Romanowska, E., Ulrich, J., and Defaye, J. (1992) Carbohydr. Res. 236, 195-208[CrossRef][Medline] [Order article via Infotrieve]
  16. Knirel, Y. A., Rietschel, E. T., Marre, R., and Zahringer, U. (1994) Eur. J. Biochem. 221, 239-245[Medline] [Order article via Infotrieve]
  17. Lewis, A. L., Nizet, V., and Varki, A. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 11123-11128[Abstract/Free Full Text]
  18. Feng, L., Senchenkova, S. N., Tao, J., Shashkov, A. S., Liu, B., Shevelev, S. D., Reeves, P. R., Xu, J., Knirel, Y. A., and Wang, L. (2005) J. Bacteriol. 187, 758-764[Abstract/Free Full Text]
  19. Berry, D. S., Lynn, F., Lee, C. H., Frasch, C. E., and Bash, M. C. (2002) Infect. Immun. 70, 3707-3713[Abstract/Free Full Text]
  20. Fattom, A. I., Sarwar, J., Basham, L., Ennifar, S., and Naso, R. (1998) Infect. Immun. 66, 4588-4592[Abstract/Free Full Text]
  21. McNeely, T. B., Staub, J. M., Rusk, C. M., Blum, M. J., and Donnelly, J. J. (1998) Infect. Immun. 66, 3705-3710[Abstract/Free Full Text]
  22. Shi, W. X., Chammas, R., Varki, N. M., Powell, L., and Varki, A. (1996) J. Biol. Chem. 271, 31526-31532[Abstract/Free Full Text]
  23. Edwards, M. S., Nizet, V., and Baker, C. J. (2006) in Infectious Diseases of the Fetus and Newborn Infant (Remington, J., Klein, J., Baker, C. J., and Wilson, C. B., eds) 6th Ed., pp. 403-464, Elsevier Saunders, Philadelphia, PA
  24. Doran, K. S., Engelson, E. J., Khosravi, A., Maisey, H. C., Fedtke, I., Equils, O., Michelsen, K. S., Arditi, M., Peschel, A., and Nizet, V. (2005) J. Clin. Investig. 115, 2499-2507[CrossRef][Medline] [Order article via Infotrieve]
  25. Jeng, A., Sakota, V., Li, Z., Datta, V., Beall, B., and Nizet, V. (2003) J. Bacteriol. 185, 1208-1217[Abstract/Free Full Text]
  26. Annunziato, P. W., Wright, L. F., Vann, W. F., and Silver, R. P. (1995) J. Bacteriol. 177, 312-319[Abstract/Free Full Text]
  27. Varki, A., and Diaz, S. (1984) Anal. Biochem. 137, 236-247[CrossRef][Medline] [Order article via Infotrieve]
  28. Tatusov, R. L., Fedorova, N. D., Jackson, J. D., Jacobs, A. R., Kiryutin, B., Koonin, E. V., Krylov, D. M., Mazumder, R., Mekhedov, S. L., Nikolskaya, A. N., Rao, B. S., Smirnov, S., Sverdlov, A. V., Vasudevan, S., Wolf, Y. I., Yin, J. J., and Natale, D. A. (2003) BMC Bioinformatics 4, 41[CrossRef][Medline] [Order article via Infotrieve]
  29. Chaffin, D. O., Mentele, L. M., and Rubens, C. E. (2005) J. Bacteriol. 187, 4615-4626[Abstract/Free Full Text]
  30. Wang, X. G., Olsen, L. R., and Roderick, S. L. (2002) Structure (Camb.) 10, 581-588
  31. Lewendon, A., Ellis, J., and Shaw, W. V. (1995) J. Biol. Chem. 270, 26326-26331[Abstract/Free Full Text]
  32. Higa, H. H., and Varki, A. (1988) J. Biol. Chem. 263, 8872-8878[Abstract/Free Full Text]
  33. Daines, D. A., Wright, L. F., Chaffin, D. O., Rubens, C. E., and Silver, R. P. (2000) FEMS Microbiol. Lett. 189, 281-284[CrossRef][Medline] [Order article via Infotrieve]
  34. Deszo, E. L., Steenbergen, S. M., Freedberg, D. I., and Vimr, E. R. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 5564-5569[Abstract/Free Full Text]
  35. Silver, R. P., Finn, C. W., Vann, W. F., Aaronson, W., Schneerson, R., Kretschmer, P. J., and Garon, C. F. (1981) Nature 289, 696-698[Medline] [Order article via Infotrieve]
  36. Malisan, F., Franchi, L., Tomassini, B., Ventura, N., Condo, I., Rippo, M. R., Rufini, A., Liberati, L., Nachtigall, C., Kniep, B., and Testi, R. (2002) J. Exp. Med. 196, 1535-1541[Abstract/Free Full Text]
  37. Moran, A. P., Rietschel, E. T., Kosunen, T. U., and Zahringer, U. (1991) J. Bacteriol. 173, 618-626[Abstract/Free Full Text]
  38. Hitoshi, S., Kusunoki, S., Kon, K., Chiba, A., Waki, H., Ando, S., and Kanazawa, I. (1996) J. Neuroimmunol. 66, 95-101[CrossRef][Medline] [Order article via Infotrieve]
  39. Koga, M., Yuki, N., Ariga, T., and Hirata, K. (1999) J. Neurol. Sci. 164, 50-55[CrossRef][Medline] [Order article via Infotrieve]
  40. Luneberg, E., Zetzmann, N., Alber, D., Knirel, Y. A., Kooistra, O., Zahringer, U., and Frosch, M. (2000) Int. J. Med. Microbiol. 290, 37-49[Medline] [Order article via Infotrieve]
  41. Angata, T., and Varki, A. (2002) Chem. Rev. 102, 439-469[CrossRef][Medline] [Order article via Infotrieve]
  42. Knirel, Y. A., Shashkov, A. S., Tsvetkov, Y. E., Jansson, P. E., and Zahringer, U. (2003) Adv. Carbohydr. Chem. Biochem. 58, 371-417[CrossRef][Medline] [Order article via Infotrieve]
  43. Zou, C. H., Knirel, Y. A., Helbig, J. H., Zahringer, U., and Mintz, C. S. (1999) J. Bacteriol. 181, 4137-4141[Abstract/Free Full Text]
  44. Kooistra, O., Luneberg, E., Lindner, B., Knirel, Y. A., Frosch, M., and Zahringer, U. (2001) Biochemistry 40, 7630-7640[Medline] [Order article via Infotrieve]
  45. Strom, M. S., and Paranjpye, R. N. (2000) Microbes Infect. 2, 177-188[CrossRef][Medline] [Order article via Infotrieve]
  46. Chattopadhyay, A., Kumar, V., Bhat, N., and Rao, P. (2002) J. Pediatr. Surg. 37, 108-110[CrossRef][Medline] [Order article via Infotrieve]
  47. Bharti, A. R., Nally, J. E., Ricaldi, J. N., Matthias, M. A., Diaz, M. M., Lovett, M. A., Levett, P. N., Gilman, R. H., Willig, M. R., Gotuzzo, E., and Vinetz, J. M. (2003) Lancet Infect. Dis. 3, 757-771[CrossRef][Medline] [Order article via Infotrieve]
  48. Daines, D. A., and Silver, R. P. (2000) J. Bacteriol. 182, 5267-5270[Abstract/Free Full Text]
  49. Vann, W. F., Daines, D. A., Murkin, A. S., Tanner, M. E., Chaffin, D. O., Rubens, C. E., Vionnet, J., and Silver, R. P. (2004) J. Bacteriol. 186, 706-712[Abstract/Free Full Text]
  50. Suryanti, V., Nelson, A., and Berry, A. (2003) Protein Expression Purif. 27, 346-356[CrossRef][Medline] [Order article via Infotrieve]
  51. Haft, R. F., and Wessels, M. R. (1994) J. Bacteriol. 176, 7372-7374[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. K. Bergfeld, H. Claus, N. K. Lorenzen, F. Spielmann, U. Vogel, and M. Muhlenhoff
The Polysialic Acid-specific O-Acetyltransferase OatC from Neisseria meningitidis Serogroup C Evolved Apart from Other Bacterial Sialate O-Acetyltransferases
J. Biol. Chem., January 2, 2009; 284(1): 6 - 16.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. B. Olivier and B. Imperiali
Crystal Structure and Catalytic Mechanism of PglD from Campylobacter jejuni
J. Biol. Chem., October 10, 2008; 283(41): 27937 - 27946.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. L. Lewis, H. Cao, S. K. Patel, S. Diaz, W. Ryan, A. F. Carlin, V. Thon, W. G. Lewis, A. Varki, X. Chen, et al.
NeuA Sialic Acid O-Acetylesterase Activity Modulates O-Acetylation of Capsular Polysaccharide in Group B Streptococcus
J. Biol. Chem., September 21, 2007; 282(38): 27562 - 27571.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
E. Severi, D. W. Hood, and G. H. Thomas
Sialic acid utilization by bacterial pathogens
Microbiology, September 1, 2007; 153(9): 2817 - 2822.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. K. Bergfeld, H. Claus, U. Vogel, and M. Muhlenhoff
Biochemical Characterization of Thepolysialic Acid-specific O-Acetyltransferase NeuO of Escherichia coli K1
J. Biol. Chem., July 27, 2007; 282(30): 22217 - 22227.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
J. R. Bishop and P. Gagneux
Evolution of carbohydrate antigens--microbial forces shaping host glycomes?
Glycobiology, May 1, 2007; 17(5): 23R - 34R.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
M. L. Warwas, J. N. Watson, A. J. Bennet, and M. M. Moore
Structure and role of sialic acids on the surface of Aspergillus fumigatus conidiospores
Glycobiology, April 1, 2007; 17(4): 401 - 410.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
A. F. Carlin, A. L. Lewis, A. Varki, and V. Nizet
Group B Streptococcal Capsular Sialic Acids Interact with Siglecs (Immunoglobulin-Like Lectins) on Human Leukocytes
J. Bacteriol., February 15, 2007; 189(4): 1231 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. M. Steenbergen, Y.-C. Lee, W. F. Vann, J. Vionnet, L. F. Wright, and E. R. Vimr
Separate Pathways for O Acetylation of Polymeric and Monomeric Sialic Acids and Identification of Sialyl O-Acetyl Esterase in Escherichia coli K1.
J. Bacteriol., September 1, 2006; 188(17): 6195 - 6206.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/16/11186    most recent
M513772200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, A. L.
Right arrow Articles by Nizet, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, A. L.
Right arrow Articles by Nizet, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement